ACPA: Erster serologischer Marker für die Wegenersche Granulomatose.

A. Beigel; W. L. Gross

ACPA: Erster serologischer Marker für die Wegenersche Granulomatose.

Translated title of the contribution: ACPA: the first serologic marker for Wegener's granulomatosis

A. Beigel^*, W. L. Gross

^*Corresponding author for this work

Department of Rheumatology and Clinical Immunology

University of Kiel

1 Citation (Scopus)

Abstract

The anticytoplasmatic autoantibody against intracytoplasmatic antigens of granulocytes (ACPA) was demonstratable in 23 patients in the active generalised or incomplete remission phase of Wegener's granulomatosis, but absent in 17 patients in the initial or complete remission phase. The test was negative in 900 serum samples from a control group. This autoantibody seems to be a marker of unusual specificity for Wegener's granuloma, and contributes to better assessment of activity in this disease.

Translated title of the contribution	ACPA: the first serologic marker for Wegener's granulomatosis
Original language	German
Journal	HNO
Volume	35
Issue number	9
Pages (from-to)	390-392
Number of pages	3
ISSN	0017-6192
Publication status	Published - 09.1987

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this

@article{91d16946afef4ebe9dd167fa7d87d4ec,

title = "ACPA: Erster serologischer Marker f{\"u}r die Wegenersche Granulomatose.",

abstract = "The anticytoplasmatic autoantibody against intracytoplasmatic antigens of granulocytes (ACPA) was demonstratable in 23 patients in the active generalised or incomplete remission phase of Wegener's granulomatosis, but absent in 17 patients in the initial or complete remission phase. The test was negative in 900 serum samples from a control group. This autoantibody seems to be a marker of unusual specificity for Wegener's granuloma, and contributes to better assessment of activity in this disease.",

author = "A. Beigel and Gross, \{W. L.\}",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "1987",

month = sep,

language = "Deutsch",

volume = "35",

pages = "390--392",

journal = "HNO",

issn = "0017-6192",

publisher = "Springer Verlag",

number = "9",

}

TY - JOUR

T1 - ACPA: Erster serologischer Marker für die Wegenersche Granulomatose.

AU - Beigel, A.

AU - Gross, W. L.

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 1987/9

Y1 - 1987/9

N2 - The anticytoplasmatic autoantibody against intracytoplasmatic antigens of granulocytes (ACPA) was demonstratable in 23 patients in the active generalised or incomplete remission phase of Wegener's granulomatosis, but absent in 17 patients in the initial or complete remission phase. The test was negative in 900 serum samples from a control group. This autoantibody seems to be a marker of unusual specificity for Wegener's granuloma, and contributes to better assessment of activity in this disease.

AB - The anticytoplasmatic autoantibody against intracytoplasmatic antigens of granulocytes (ACPA) was demonstratable in 23 patients in the active generalised or incomplete remission phase of Wegener's granulomatosis, but absent in 17 patients in the initial or complete remission phase. The test was negative in 900 serum samples from a control group. This autoantibody seems to be a marker of unusual specificity for Wegener's granuloma, and contributes to better assessment of activity in this disease.

UR - https://www.scopus.com/pages/publications/0023413998

M3 - Zeitschriftenaufsätze

C2 - 3312127

AN - SCOPUS:0023413998

SN - 0017-6192

VL - 35

SP - 390

EP - 392

JO - HNO

JF - HNO

IS - 9

ER -

ACPA: Erster serologischer Marker für die Wegenersche Granulomatose.

Abstract

UN SDGs

Research Areas and Centers

Other files and links

Fingerprint

Cite this